d3 Medicine

d3 Medicine is a strategic advisory company based in Parsippany, New Jersey. The company is comprised of three employees and generates an annual revenue of $2.5 million. d3 Medicine specializes in assisting organizations in the development of novel medicines for a range of therapeutic areas including infectious diseases, oncology, and inflammation. Their advisory services encompass the entire drug discovery and development process. These services include the creation of Target Product Profiles and Clinical Development Plans, conducting technical due diligence, supporting licensing and mergers and acquisitions, and providing input on discovery programs and drug screening strategies. d3 Medicine also specializes in projecting human starting and efficacious doses using modeling and simulation, formulating translational medicine strategies for expedited preclinical development, and developing creative regulatory strategies to accelerate clinical trials. The company emphasizes the use of modeling and simulation applications to enhance decision-making throughout all stages of the drug development process. They aim to be at the forefront of innovation in development methods, regulatory science, and policy. For more information on d3 Medicine and its services, please visit their website at d3medicine.com.